Matthias Stelljes

Matthias Stelljes

UNVERIFIED PROFILE

Are you Matthias Stelljes?   Register this Author

Register author
Matthias Stelljes

Matthias Stelljes

Publications by authors named "Matthias Stelljes"

Are you Matthias Stelljes?   Register this Author

100Publications

3012Reads

42Profile Views

The role of allogeneic stem cell transplantation in T-cell lymphoma.

Curr Opin Oncol 2018 09;30(5):301-307

Department of Medicine A (Hematology, Oncology, Hemostaseology and Pulmonology), University Hospital Muenster, Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000473DOI Listing
September 2018

Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas.

Blood 2018 Jul 26;132(3):245-253. Epub 2018 Apr 26.

Department of Medicine A, University Hospital Münster, Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-01-791335DOI Listing
July 2018

Radiotherapy for extramedullary leukaemic manifestation (Chloroma).

Strahlenther Onkol 2018 02 16;194(2):164-173. Epub 2017 Nov 16.

Department of Radiation Oncology, University Hospital of Muenster, Albert-Schweitzer-Campus 1, Building A1, 48149, Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-017-1236-4DOI Listing
February 2018

Therapy of older persons with acute myeloid leukaemia.

Leuk Res 2017 09 1;60:1-10. Epub 2017 Jun 1.

University Hospital Münster, Department of Medicine A, Albert-Schweitzer-Campus 1, Geb. A1, 48129 Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.05.020DOI Listing
September 2017

Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis.

Acta Haematol 2017 12;137(3):163-172. Epub 2017 Apr 12.

Department of Oncology, Hematology, and Bone Marrow Transplantation with Section of Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000463534DOI Listing
July 2017

Successful second allogeneic stem cell transplantation in a patient with T-lymphoblastic leukemia (T-ALL) relapsed as myeloid sarcoma.

Ann Hematol 2017 Jul 27;96(7):1201-1203. Epub 2017 Apr 27.

Department of Medicine A, Hematology and Oncology, University of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-017-3000-3
Publisher Site
http://dx.doi.org/10.1007/s00277-017-3000-3DOI Listing
July 2017

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial).

J Clin Oncol 2017 Jul 2;35(19):2157-2164. Epub 2017 May 2.

Nicolaus Kröger, University Medical Center Hamburg-Eppendorf, Hamburg; Georg-Nikolaus Franke, University Hospital Leipzig, Leipzig; Uwe Platzbecker, University Hospital Dresden, Dresden; Kai Hübel and Christof Scheid, University of Cologne, Cologne; Thomas Weber, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle; Matthias Stelljes, University of Münster, Münster; Peter Dreger, University of Heidelberg, Heidelberg; Andreas Günther, University Hospital Schleswig Holstein Campus Kiel, Kiel; Wolfgang Bethge, University Hospital Tübingen, Tübingen; Guido Kobbe, Heinrich Heine University, Düsseldorf, Germany; Simona Iacobelli, Università Tor Vergata, Rome; Giorgio Lambertenghi Deliliers and Francesco Onida, Fondazione IRCC Ca' Granda Ospedale Maggiore Policlinico, University of Milano, Milan; Massimo Pini, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria; Stefano Guidi, Azienda Ospedaliera Universitaria Careggi, Florence, Italy; Ruzena Uddin, Guy's Hospital, London, United Kingdom; Marie Robin, Hôpital Saint Louis, Assistance Publique Hôpitaux Paris, France; Boris Afanasyev, SPB Pavlov Medical University, St Petersburg, Russia; Dominik Heim, University Hospital Basel, Basel Switzerland; Liisa Volin, Helsinki University Hospital, Helsiniki, Finland; Xavier Poiré, Cliniques Universitaires St-Luc, Brussels, Belgium; Marleen van Os, European Group of Blood and Marrow Transplantation Clinical Trials Office; Ronald Brand, Leiden University Medical Center, Leiden; and Theo de Witte, Radboud University Medical Center, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.7349DOI Listing
July 2017

Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT.

Cancer 2017 06 17;123(11):1965-1970. Epub 2017 Feb 17.

Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer and Sackler School of Medicine, Ramat Gan, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30604DOI Listing
June 2017

Epileptic seizures and rhinocerebral mucormycosis during blinatumomab treatment in a patient with biphenotypic acute leukemia.

Ann Hematol 2017 Jan 3;96(1):151-153. Epub 2016 Oct 3.

Department of Medicine A/Hematology and Oncology, University of Muenster, Albert-Schweitzer-Campus 1, D-48149, Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2837-1DOI Listing
January 2017

Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.

N Engl J Med 2016 Aug 12;375(8):740-53. Epub 2016 Jun 12.

From the University of Texas MD Anderson Cancer Center, Houston (H.M.K.); the Dana-Farber Cancer Institute, Boston (D.J.D.), and Pfizer, Cambridge (E.V.) - both in Massachusetts; Universitätsklinikum Münster, Münster (M.S.), and Goethe University, Frankfurt (N.G.) - both in Germany; Institute Seràgnoli, DIMES (Department of Experimental, Diagnostic and Specialty Medicine), University of Bologna, Bologna, Italy (G.M.); Stanford Cancer Institute, Stanford (M.L.), and the University of California, Irvine Medical Center, Orange (S.O.) - both in California; the University of Chicago, Chicago (W.S.); Pfizer, Pearl River, NY (K.W.); Pfizer, Groton, CT (T.W., M.L.P., B.S.); and Cleveland Clinic, Cleveland (A.S.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1509277DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594743PMC
August 2016

MYST2 acetyltransferase expression and Histone H4 Lysine acetylation are suppressed in AML.

Exp Hematol 2015 Sep 11;43(9):794-802.e4. Epub 2015 Jun 11.

Department of Medicine A, Hematology, Hemostaseology, Oncology and Pneumology, University of Muenster, Muenster, Germany; Department of Medicine, Hematology and Oncology, University of Halle, Halle, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2015.05.010DOI Listing
September 2015

Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial.

J Clin Oncol 2015 Feb 29;33(5):403-10. Epub 2014 Dec 29.

Christoph Röllig, Martin Bornhäuser, Michael Kramer, Christian Thiede, Uwe Platzbecker, Martin Wermke, Friedrich Stölzel, Malte von Bonin, Markus Schaich, Johannes Schetelig, and Gerhard Ehninger, Medizinische Klinik und Poliklinik I, Universitätsklinikum der Technischen Universität Dresden; Johannes Schetelig, DKMS, German Bone Marrow Donor Center, Dresden; Anthony D. Ho and Alwin Krämer, Medizinische Universitätsklinik, Abteilung Innere Medizin V, Heidelberg; Kerstin Schäfer-Eckart and Hannes Wandt, 5. Medizinische Klinik, Klinikum Nürnberg, Nürnberg; Mathias Hänel, Klinik für Innere Medizin III, Klinikum Chemnitz, Chemnitz; Hermann Einsele, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg; Walter E. Aulitzky, Robert-Bosch-Krankenhaus, Stuttgart; Norbert Schmitz, Abteilung für Hämatologie, Onkologie und Stammzelltransplantation, ASKLEPIOS Klinik St Georg, Hamburg; Wolfgang E. Berdel, Matthias Stelljes, and Utz Krug, Medizinische Klinik A, Universitätsklinikum Münster, Münster; Carsten Müller-Tidow, Universitätsklinik und Poliklinik für Innere Medizin IV, Universitätsklinikum Halle, Halle (Saale); Claudia D. Baldus, Medizinische Klinik III, Charité-Universitätsmedizin Berlin, Charité Centrum 14, Campus Benjamin Franklin, Berlin; Stefan W. Krause, Medizinische Klinik 5, Universitätsklinikum Erlangen, Erlangen; and Hubert Serve, Medizinische Klinik II, Universitätsklinikum Frankfurt, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.4973DOI Listing
February 2015

Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia.

J Clin Oncol 2014 Dec 10;32(36):4134-40. Epub 2014 Nov 10.

Max S. Topp, Hermann Einsele, and Ralf C. Bargou, Universitätsklinikum Würzburg, Würzburg; Nicola Gökbuget, Goethe University; Dieter Hoelzer, Onkologikum, Frankfurt; Gerhard Zugmaier, Petra Klappers, and Noemi Mergen, Amgen Research; Dorothea Wessiepe, Metronomia, Munich; Matthias Stelljes, University of Münster, Münster; Svenja Neumann, Heinz-August Horst, and Monika Brüggemann, University Schleswig Holstein, City Hospital, Kiel; Andreas Viardot, University of Ulm, Ulm; Reinhard Marks, Universitätsklinikum Freiburg, Freiburg; Helmut Diedrich, Medizinische Hochschule Hannover, Hannover; Christoph Faul, Universitätsklinikum Tübingen, Tübingen; Albrecht Reichle, Universitätsklinikum Regensburg, Regensburg, Germany; and Chris Holland and Shilpa Alekar, Amgen, Rockville, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.3247DOI Listing
December 2014

Who is the best hematopoietic stem-cell donor for a male patient with acute leukemia?

Transplantation 2014 Sep;98(5):569-77

1 Center for Allogeneic Stem Cell Transplantation and Division of Therapeutic Immunology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden. 2 Department of Haematology, Hôpital Saint Antoine, Paris, France. 3 Department of Bone Marrow Transplantation, Essen, University Hospital, Essen, Germany. 4 Medizinische Klinik m. S. Hämatologie/Onkologie, Charité Universitätsmedizin, Berlin, Germany. 5 Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden, Germany. 6 CHU Bordeaux, Hôpital Haut-leveque, Pessac, France. 7 Division of Hematology, Oncology and Hemostasiology, University Hospital Leipzig, Leipzig, Germany. 8 Service Hématologie Greffe de Moelle, Centre Pierre et Marie Curie, Alger, Algeria. 9 Department of Hematology and BMT, Silesian Medical Academy, Katowice, Poland. 10 Department of Hematology/Oncology, Hannover Medical University, Hannover, Germany. 11 Department of Hematology - BMT, Hôpital St. Louis, Paris, France. 12 Department of Hematology/Oncology, University of Münster, Münster, Germany. 13 Division of Hematology, Helsinki University Central Hospital, Helsinki, Finland. 14 Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom. 15 Address correspondence to: Olle Ringdén, M.D., Ph.D., Karolinska Institutet, Division of Therapeutic Immunology, Karolinska University Hospital Huddinge, F79, SE-141 86 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000000102DOI Listing
September 2014

Resilience in patients after allogeneic stem cell transplantation.

Support Care Cancer 2014 Feb 8;22(2):487-93. Epub 2013 Oct 8.

Department of Medicine A/Hematology and Oncology, University of Muenster, Albert-Schweitzer-Campus 1, Bldg. A 1, 48149, Muenster, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-013-2001-6DOI Listing
February 2014

Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis.

J Clin Oncol 2014 Feb 23;32(4):288-96. Epub 2013 Dec 23.

Matthias Stelljes, Utz Krug, Maria C. Sauerland, Achim Heinecke, Sandra Ligges, Tim Sauer, Petra Tschanter, Gabriela B. Thoennissen, Björna Berning, Carsten Müller-Tidow, Wolfgang E. Berdel, and Thomas Büchner, University Hospital of Muenster, Muenster; Dietrich W. Beelen, University Hospital of Essen, Essen; Jan Braess, Krankenhaus Barmherzige Brüder; Albrecht Reichle, Ernst Holler, University of Regensburg, Regensburg; Hans J. Kolb, Wolfgang Hiddeman, University of Munich-Grosshadern, Munich; Rainer Schwerdtfeger, Deutsche Klinik für Diagnostik, Wiesbaden; Renate Arnold, Charité, Universitätsmedizin Berlin, Campus Virchow-Klinikum; Bernhard J. Woermann, German Society of Hematology and Oncology, Berlin; and Christoph Scheid, University of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.5768DOI Listing
February 2014

Non-invasive ventilation in immunosuppressed patients with pneumonia and extrapulmonary sepsis.

Respir Med 2012 Nov 1;106(11):1509-16. Epub 2012 Sep 1.

Department of Cardiology und Angiology, University Hospital of Muenster, Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2012.08.007DOI Listing
November 2012

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.

Blood Cells Mol Dis 2008 Jan-Feb;40(1):13-9. Epub 2007 Sep 14.

Medical Center, University of Tübingen, Hematology/Oncology Otfried-Mueller Str. 1072076 Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2007.07.001DOI Listing
February 2008

Forodesine treatment and post-transplant graft-versus-host disease in two patients with acute leukemia: facilitation of graft-versus-leukemia effect?

Semin Oncol 2007 Dec;34(6 Suppl 5):S35-9

Section of Hematology/Oncology/BMT, Department of Pediatrics, University of Colorado School of Medicine and The Children's Hospital, Denver, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2007.11.005DOI Listing
December 2007

Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.

Br J Haematol 2005 Jan;128(2):177-83

Department of Haematology, Oncology and Transfusion Medicine, Charite Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2004.05284.xDOI Listing
January 2005